Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3126 (LINC03126) does not correspond to a validated or annotated gene or transcript in current genomic databases or the published literature as of September 2025. No molecular, biological, or clinical data exist to support its classification as a functional lincRNA or its involvement in specific cellular processes or diseases. The name may be a result of a typographical error or an unvalidated/experimental identifier. Correct, established targets in the lincRNA space include well-characterized species such as LINC00665, LINC00312, and LINC00460, which have defined expressions, functions, and roles in disease, particularly cancer[2][3]. If the target was intended to reference an existing lincRNA, it is advised to verify the correct identifier and spelling. If new, unpublished data exists on LINC03126, it should be made available in a peer-reviewed context for further evaluation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3126 (LINC03126) (LINC03126).